LGND CIK: 886163

Ligand Pharmaceuticals Incorporated

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.46
FY22:
0.26
FY23:
0.24
FY24:
0.33
FY25:
0.83
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.83
FY22:
0.50
FY23:
0.55
FY24:
0.61
FY25:
0.73
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.30
FY22:
0.76
FY23:
0.79
FY24:
0.94
FY25:
1.56

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.04
FY22:
0.10
FY23:
0.02
FY24:
0.04
FY25:
0.04
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.43
FY22:
0.07
FY23:
0.07
FY24:
0.07
FY25:
0.51
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.82
FY22:
0.60
FY23:
0.70
FY24:
0.83
FY25:
1.02
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.30
FY22:
0.76
FY23:
0.79
FY24:
0.94
FY25:
1.56

All amounts in billions USD Data source:SEC EDGAR